Letters to the Editor

Outstanding outcomes in infants with KMT2A-germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children’s Oncology Group AALL0631 trial

Division of Hematology/Oncology/Blood and Marrow Transplantation, Children’s Mercy Kansas City, Kansas City, MO
Department of Biostatistics, Colleges of Medicine, Public Health and Health Professions, University of Florida, Gainesville, FL
Center for Cancer and Blood Disorders, Children’s Hospital Colorado, Aurora, CO
Texas Children’s Hospital, Houston, TX
Department of Genetics, University of Alabama at Birmingham, Birmingham, AL
The Ohio State University Comprehensive Cancer Center, Columbus, OH
Department of Biostatistics, Colleges of Medicine, Public Health and Health Professions, University of Florida, Gainesville, FL
Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN
Center for Cancer and Blood Disorders, Children’s Hospital Colorado, Aurora, CO
U.S. Army Medical Research and Materiel Command, Fort Detrick, MD
Division of Pediatric Hematology/Oncology, University of Texas Southwestern School of Medicine, Dallas, TX
Department of Pediatrics and Perlmutter Cancer Center, NYU Langone Health, New York, NY
Department of Pediatrics and Perlmutter Cancer Center, NYU Langone Health, New York, NY
Departments of Pathology and Oncology, Johns Hopkins University, Baltimore, MD
Department of Pediatrics, Benioff Children's Hospital in the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA
Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
Vol. 107 No. 5 (2022): May, 2022 https://doi.org/10.3324/haematol.2021.280146